Altimmune: Pemvidutide Differentiation Advancement In MASH Space Continues To Shine
Explore the promising potential of Altimmune, Inc.'s Pemvidutide in NASH, AUD, & obesity treatment, with key trials underway.
Health and Me on MSN34m
Urologist Shares 'Itchy And Ugly' Symptoms Of Kidney Diseases Visible On Your Skin
Your skin might be telling you something serious! Unexplained itching, discoloration, or extreme dryness could be hidden ...
Verywell Health on MSN5h
Can ‘Eating Your Retinol’ Really Improve Your Skin?
Eating your retinol is one of the latest social media skincare trends. What do dermatologists and dietitians think?
Travere Therapeutics Submits sNDA to FDA for Approval of FILSPARI® (sparsentan) for the Treatment of FSGS
NDA submission based on results from Phase 3 DUPLEX and Phase 2 DUET studies of FILSPARI in FSGSIf approved, FILSPARI could become the first and ...
Travere Therapeutics, Inc.: Travere Therapeutics Submits sNDA to FDA for Approval of FILSPARI (sparsentan) for the Treatment of FSGS
NDA submission based on results from Phase 3 DUPLEX and Phase 2 DUET studies of FILSPARI in FSGS If approved, FILSPARI could become the first and only FDA-approved treatment for FSGS, a rare kidney ...
Best vitamin B12 supplements that are expert-approved
Despite our best efforts to balance the optimal quantity of fibre, fat, carbohydrates and protein, we may sometimes fall ...
Doctors assured me I was cancer-free after removing 60% of my liver - but just 6 weeks later they told me I had less than 3 years to live
Michelle Black, 50, from Hertfordshire, who was told she was cancer-free, was given less than three years to live just six ...
Journavx: What to Know About the New Nonopioid Painkiller
After you've had surgery or experienced a serious physical injury, you are more than likely going to be in a lot of pain. No matter what your pain tolerance is, recovering from surgery or any ...